Overview
Cystic fibrosis (CF) is a complex, life-threatening condition that affects approximately 70,000 people worldwide. It is characterized by the production of thick, sticky mucus that clogs the airways, digestive system, and other organs, leading to respiratory infections, malnutrition, and other complications. The disease is caused by a mutation in the
CFTR (cystic fibrosis transmembrane conductance regulator) gene, which codes for a protein responsible for regulating the movement of salt and water in and out of cells.
CF is a multisystem disorder, affecting not only the lungs but also the pancreas, liver, kidneys, and reproductive organs. In the lungs, the thick mucus traps bacteria, leading to recurrent pneumonia and bronchitis. In the pancreas, the mucus blocks the release of digestive enzymes, causing malabsorption of nutrients. The liver and kidneys may also be affected, leading to cirrhosis and renal failure.
History/Background
Cystic fibrosis was first described in 1938 by
Dr. Dorothy Andersen, an American pathologist who identified the characteristic
cystic changes in the pancreas of affected individuals. However, the genetic basis of the disease was not understood until the 1980s, when the
CFTR gene was cloned. Since then, significant advances have been made in the diagnosis, treatment, and management of CF, including the development of
genetic testing,
newborn screening, and
targeted therapies.
Key Information
-
Genetics: CF is inherited in an
autosomal recessive pattern, meaning that a person must inherit two copies of the mutated gene (one from each parent) to develop the condition.
-
Symptoms: Common symptoms include
persistent cough,
wheezing,
shortness of breath,
malnutrition, and
repeated lung infections.
-
Diagnosis: Diagnosis is typically made through a combination of
genetic testing,
newborn screening, and
physical examination.
-
Treatment: Treatment involves a combination of
medications,
lifestyle modifications, and
surgical interventions, such as
lung transplantation.
-
Prognosis: With proper treatment, individuals with CF can lead active, productive lives, but the disease is still
life-limiting, and mortality rates remain high.
Significance
Cystic fibrosis is a significant public health concern, affecting individuals and families worldwide. The development of new treatments and therapies has improved the quality of life for individuals with CF, but more research is needed to understand the underlying mechanisms of the disease and to develop more effective treatments. The
Cystic Fibrosis Foundation has played a crucial role in advancing research and improving care for individuals with CF.
